|Bid||35.95 x 1800|
|Ask||36.10 x 2200|
|Day's Range||35.93 - 36.17|
|52 Week Range||31.60 - 41.14|
|Beta (5Y Monthly)||0.72|
|PE Ratio (TTM)||9.28|
|Forward Dividend & Yield||2.98 (8.02%)|
|Ex-Dividend Date||Sep 30, 2021|
|1y Target Est||50.06|
Altria (MO) strives to expand IQOS and on! amid consumers' rising preference on low-risk tobacco alternatives. Moreover, strong pricing for tobacco products is driving revenues.
The FDA authorized marketing of the first e-cigarette products, and several others are under review.
Shares of British American Tobacco and other makers of e-cigarettes were rising Wednesday after the Food and Drug Administration approved an e-cigarette in the U.S. for the first time. U.S.-listed shares of British American Tobacco (ticker: BTI) were up 2% to $35.44. The FDA authorized e-cigarettes and tobacco-flavored pods made by Vuse, which are produced by RJ Reynolds, a unit of British American Tobacco.